|
US487000A
(en)
|
|
1892-11-29 |
|
Shirt |
|
US2832685A
(en)
|
1952-05-24 |
1958-04-29 |
Crest Foods Co Inc |
Solubilization of milk proteins
|
|
GB894095A
(en)
|
1960-02-08 |
1962-04-18 |
Tanaka Shoichi |
A therapeutic device for personal wear
|
|
US3528960A
(en)
|
1968-10-07 |
1970-09-15 |
Lilly Co Eli |
N-carboxyaroyl insulins
|
|
US3719655A
(en)
|
1969-12-05 |
1973-03-06 |
Lilly Co Eli |
Process for the crystallization of the ammonium and alkali metal salts in insulin
|
|
US3869437A
(en)
|
1970-05-08 |
1975-03-04 |
Nat Res Dev |
Mono-, di, and N{HD A1{B , N{HU B1{B , N{HU B29{B -tri-acylated insulin
|
|
US3950517A
(en)
|
1970-05-08 |
1976-04-13 |
National Research Development Corporation |
Insulin derivatives
|
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US4033941A
(en)
|
1975-12-17 |
1977-07-05 |
Eli Lilly And Company |
Process for purifying glucagon
|
|
GB1492997A
(en)
|
1976-07-21 |
1977-11-23 |
Nat Res Dev |
Insulin derivatives
|
|
JPS6030650B2
(ja)
|
1979-10-26 |
1985-07-17 |
日本油脂株式会社 |
座薬基剤組成物
|
|
JPS5767548A
(en)
|
1980-10-14 |
1982-04-24 |
Shionogi & Co Ltd |
Insulin analog and its preparation
|
|
NL193099C
(nl)
|
1981-10-30 |
1998-11-03 |
Novo Industri As |
Gestabiliseerde insuline-oplossing.
|
|
US4546082A
(en)
|
1982-06-17 |
1985-10-08 |
Regents Of The Univ. Of California |
E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins
|
|
US4870008A
(en)
|
1983-08-12 |
1989-09-26 |
Chiron Corporation |
Secretory expression in eukaryotes
|
|
US4839341A
(en)
|
1984-05-29 |
1989-06-13 |
Eli Lilly And Company |
Stabilized insulin formulations
|
|
DK347086D0
(da)
|
1986-07-21 |
1986-07-21 |
Novo Industri As |
Novel peptides
|
|
PH25772A
(en)
|
1985-08-30 |
1991-10-18 |
Novo Industri As |
Insulin analogues, process for their preparation
|
|
US4849227A
(en)
|
1986-03-21 |
1989-07-18 |
Eurasiam Laboratories, Inc. |
Pharmaceutical compositions
|
|
PH23446A
(en)
|
1986-10-20 |
1989-08-07 |
Novo Industri As |
Peptide preparations
|
|
NZ222907A
(en)
|
1986-12-16 |
1990-08-28 |
Novo Industri As |
Preparation for intranasal administration containing a phospholipid absorption enhancing system
|
|
DK463887D0
(da)
|
1987-09-07 |
1987-09-07 |
Novo Industri As |
Gaerleader
|
|
US5266310A
(en)
|
1987-09-17 |
1993-11-30 |
Boehringer Ingelheim International Gmbh |
Stabilization of therapeutically active proteins in pharmaceutical preparations
|
|
JPH01254699A
(ja)
|
1988-04-05 |
1989-10-11 |
Kodama Kk |
インスリン誘導体及びその用途
|
|
DK257988D0
(da)
|
1988-05-11 |
1988-05-11 |
Novo Industri As |
Nye peptider
|
|
US5149777A
(en)
|
1988-07-20 |
1992-09-22 |
Novo Nordisk A/S |
Human insulin analogs and preparations containing them
|
|
KR0148748B1
(ko)
|
1988-09-16 |
1998-08-17 |
장 크라메르, 한스 루돌프 하우스 |
사이클로스포린을 함유하는 약학조성물
|
|
US5225323A
(en)
|
1988-11-21 |
1993-07-06 |
Baylor College Of Medicine |
Human high-affinity neurotransmitter uptake system
|
|
JPH04502465A
(ja)
|
1988-12-23 |
1992-05-07 |
ノボ ノルディスク アクティーゼルスカブ |
ヒトインシュリン類似物質
|
|
US5716927A
(en)
|
1988-12-23 |
1998-02-10 |
Novo Nordisk A/S |
Insulin analogs having a modified B-chain
|
|
DE3844211A1
(de)
|
1988-12-29 |
1990-07-05 |
Hoechst Ag |
Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
|
|
DK105489D0
(da)
|
1989-03-03 |
1989-03-03 |
Novo Nordisk As |
Polypeptid
|
|
US5514646A
(en)
|
1989-02-09 |
1996-05-07 |
Chance; Ronald E. |
Insulin analogs modified at position 29 of the B chain
|
|
AU631868B2
(en)
|
1989-04-20 |
1992-12-10 |
Mount Sinai School Of Medicine Of The City University Of New York, The |
Hepatospecific insulin analogues
|
|
CA1340994C
(en)
|
1989-09-21 |
2000-05-16 |
Rudolf Edgar Dr. Falk |
Treatment of conditions and disease
|
|
WO1991003935A1
(en)
|
1989-09-22 |
1991-04-04 |
Tsi-Mason Research Institute |
Method and compositions for one-step cryopreservation of embryos
|
|
AU628674B2
(en)
|
1989-10-19 |
1992-09-17 |
Nippon Oil And Fats Company, Limited |
Polymer complexes of a sugar response type
|
|
US5179189A
(en)
|
1990-01-19 |
1993-01-12 |
Nova Pharmaceutical Corporation |
Fatty acid terminated polyanhydrides
|
|
DK45590D0
(hu)
|
1990-02-21 |
1990-02-21 |
Novo Nordisk As |
|
|
DK155690D0
(da)
|
1990-06-28 |
1990-06-28 |
Novo Nordisk As |
Nye peptider
|
|
DK158390D0
(da)
|
1990-07-02 |
1990-07-02 |
Novo Nordisk As |
Nye peptider
|
|
AU8091091A
(en)
|
1990-07-26 |
1992-02-18 |
University Of Iowa Research Foundation, The |
Novel drug delivery systems for proteins and peptides using albumin as a carrier molecule
|
|
EP0548238A1
(en)
|
1990-09-13 |
1993-06-30 |
Smithkline Beecham Corporation |
Non-aqueous liquid oral suspensions
|
|
DK10191D0
(da)
|
1991-01-22 |
1991-01-22 |
Novo Nordisk As |
Hidtil ukendte peptider
|
|
US5336782A
(en)
|
1991-04-24 |
1994-08-09 |
Kuraray Co., Ltd. |
Long chain carboxylic acid imide ester
|
|
WO1998017320A1
(en)
|
1991-07-03 |
1998-04-30 |
Hyal Pharmaceutical Corporation |
Use of hyaluronan in gene therapy
|
|
ES2093269T3
(es)
|
1991-07-26 |
1996-12-16 |
Smithkline Beecham Corp |
Microemulsiones del tipo agua en aceite.
|
|
US5268453A
(en)
|
1991-08-08 |
1993-12-07 |
Scios Inc. |
Tissue-selective insulin analogs
|
|
US5206219A
(en)
|
1991-11-25 |
1993-04-27 |
Applied Analytical Industries, Inc. |
Oral compositions of proteinaceous medicaments
|
|
CZ342492A3
(en)
|
1991-11-26 |
1993-06-16 |
Lilly Co Eli |
Derivatives of tri-arginine insulin, process of their preparation and a pharmaceutical composition in which said derivatives are comprised
|
|
EP0547544B1
(de)
|
1991-12-18 |
1997-03-12 |
Hoechst Aktiengesellschaft |
Verfahren zur Gewinnung von insulinhaltigen Lösungen
|
|
WO1994008599A1
(en)
|
1992-10-14 |
1994-04-28 |
The Regents Of The University Of Colorado |
Ion-pairing of drugs for improved efficacy and delivery
|
|
JPH08502490A
(ja)
|
1992-10-16 |
1996-03-19 |
スミスクライン・ビーチャム・コーポレイション |
組成物
|
|
EP0666752A4
(en)
|
1992-10-16 |
1996-09-11 |
Smithkline Beecham Corp |
THERAPEUTIC MICROEMULSIONS.
|
|
WO1994019003A1
(en)
|
1993-02-17 |
1994-09-01 |
Smithkline Beecham Corporation |
Microemulsions comprising therapeutic peptides
|
|
WO1994019001A1
(en)
|
1993-02-17 |
1994-09-01 |
Smithkline Beecham Corporation |
Microemulsions comprising therapeutic peptides
|
|
ATE197550T1
(de)
|
1993-02-23 |
2000-12-15 |
Genentech Inc |
Stabilisierung von mit organischen lösungsmittel behandelten polypeptiden mit einem hilfsstoff
|
|
US5359030A
(en)
|
1993-05-10 |
1994-10-25 |
Protein Delivery, Inc. |
Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
|
|
US5424286A
(en)
|
1993-05-24 |
1995-06-13 |
Eng; John |
Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
|
|
US5506203C1
(en)
|
1993-06-24 |
2001-02-06 |
Astra Ab |
Systemic administration of a therapeutic preparation
|
|
DK82893D0
(da)
|
1993-07-08 |
1993-07-08 |
Novo Nordisk As |
Peptid
|
|
US6869930B1
(en)
|
1993-09-17 |
2005-03-22 |
Novo Nordisk A/S |
Acylated insulin
|
|
RO112873B1
(ro)
|
1993-09-17 |
1998-01-30 |
Novo Nordisk As |
Derivati de insulina
|
|
GB9323588D0
(en)
|
1993-11-16 |
1994-01-05 |
Cortecs Ltd |
Hydrophobic preparation
|
|
CA2183577C
(en)
|
1994-03-07 |
2007-10-30 |
John S. Patton |
Methods and compositions for pulmonary delivery of insulin
|
|
US5639642A
(en)
|
1994-06-16 |
1997-06-17 |
Novo Nordisk A/S |
Synthetic leader peptide sequences
|
|
US6500645B1
(en)
|
1994-06-17 |
2002-12-31 |
Novo Nordisk A/S |
N-terminally extended proteins expressed in yeast
|
|
ZA954983B
(en)
|
1994-06-17 |
1996-02-14 |
Novo Nordisk As |
N-terminally extended proteins expressed in yeast
|
|
US5693609A
(en)
|
1994-11-17 |
1997-12-02 |
Eli Lilly And Company |
Acylated insulin analogs
|
|
US5646242A
(en)
|
1994-11-17 |
1997-07-08 |
Eli Lilly And Company |
Selective acylation of epsilon-amino groups
|
|
US6251856B1
(en)
|
1995-03-17 |
2001-06-26 |
Novo Nordisk A/S |
Insulin derivatives
|
|
CZ289343B6
(cs)
|
1995-03-17 |
2002-01-16 |
Novo Nordisk A/S |
Inzulinový derivát a farmaceutický prostředek pro léčení diabetes
|
|
US5824638A
(en)
|
1995-05-22 |
1998-10-20 |
Shire Laboratories, Inc. |
Oral insulin delivery
|
|
US20010041786A1
(en)
|
1995-06-07 |
2001-11-15 |
Mark L. Brader |
Stabilized acylated insulin formulations
|
|
WO1997002043A1
(en)
|
1995-06-30 |
1997-01-23 |
Novo Nordisk A/S |
Prevention of a disease having the characteristics of diabetes
|
|
US20030104981A1
(en)
|
1995-11-03 |
2003-06-05 |
Jelena Mandic |
Human insulin analogues
|
|
US6451970B1
(en)
|
1996-02-21 |
2002-09-17 |
Novo Nordisk A/S |
Peptide derivatives
|
|
AU3255397A
(en)
|
1996-07-05 |
1998-02-02 |
Novo Nordisk A/S |
Method for the production of precursors of insulin, precursors of insulin analogues, and insulin like peptides
|
|
DE69731105T2
(de)
|
1996-07-11 |
2005-11-17 |
Novo Nordisk A/S |
Verfahren zur selektiven acetylierung
|
|
US5981489A
(en)
|
1996-07-18 |
1999-11-09 |
Alza Corporation |
Non-aqueous protic peptide formulations
|
|
DK0821006T3
(da)
|
1996-07-26 |
2004-08-16 |
Aventis Pharma Gmbh |
Insulinderivater med öget zinkbinding
|
|
IL119029A0
(en)
|
1996-08-07 |
1996-11-14 |
Yeda Res & Dev |
Long-acting drugs and pharamaceutical compositions comprising them
|
|
ES2283025T3
(es)
|
1996-08-30 |
2007-10-16 |
Novo Nordisk A/S |
Derivados de glp-1.1.
|
|
AU5549998A
(en)
|
1997-01-24 |
1998-08-18 |
Novo Nordisk A/S |
Synthetic leader peptide sequences
|
|
HUP0001013A3
(en)
|
1997-01-30 |
2004-10-28 |
Novartis Ag |
Oil-free pharmaceutical compositions containing cyclosporin a
|
|
US5898067A
(en)
|
1997-02-07 |
1999-04-27 |
Novo Nordisk A/S |
Crystallization of proteins
|
|
US6310038B1
(en)
|
1997-03-20 |
2001-10-30 |
Novo Nordisk A/S |
Pulmonary insulin crystals
|
|
CO4750643A1
(es)
|
1997-06-13 |
1999-03-31 |
Lilly Co Eli |
Formulacion estable de la insulina que contiene l-arginina y protamina
|
|
JP2001521006A
(ja)
|
1997-10-24 |
2001-11-06 |
イーライ・リリー・アンド・カンパニー |
不溶性インシュリン組成物
|
|
ES2202899T3
(es)
|
1997-10-24 |
2004-04-01 |
Novo Nordisk A/S |
Agregados de derivados de la insulina humana.
|
|
ZA989744B
(en)
|
1997-10-31 |
2000-04-26 |
Lilly Co Eli |
Method for administering acylated insulin.
|
|
AU1375199A
(en)
|
1997-11-12 |
1999-05-31 |
Alza Corporation |
Method for decreasing self-association of polypeptides
|
|
CO4970787A1
(es)
|
1997-12-23 |
2000-11-07 |
Lilly Co Eli |
Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea
|
|
EP1060191B1
(en)
|
1998-02-27 |
2010-04-28 |
Novo Nordisk A/S |
Derivatives of glp-1 analogs
|
|
WO1999065941A1
(en)
|
1998-06-12 |
1999-12-23 |
Kings College London |
Insulin analogue
|
|
GB9814172D0
(en)
|
1998-06-30 |
1998-08-26 |
Andaris Ltd |
Formulation for inhalation
|
|
US7056734B1
(en)
|
1998-08-10 |
2006-06-06 |
The United States Of America As Represented By The Department Of Health And Human Services, Nih |
Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereof
|
|
WO2000010541A1
(en)
|
1998-08-25 |
2000-03-02 |
Advanced Inhalation Research, Inc. |
Stable spray-dried protein formulations
|
|
TW570805B
(en)
|
1998-09-01 |
2004-01-11 |
Hoffmann La Roche |
Water-soluble pharmaceutical composition in an ionic complex
|
|
US7030083B2
(en)
|
1998-09-09 |
2006-04-18 |
University Of Washington |
Treatment of eclampsia and preeclampsia
|
|
HUP0104111A3
(en)
|
1998-10-16 |
2002-05-28 |
Novo Nordisk As |
Stable concentrated insulin preparations for pulmonary delivery
|
|
US6660715B2
(en)
|
1998-11-19 |
2003-12-09 |
Massachusetts Institute Of Technology |
Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
|
|
US7425541B2
(en)
|
1998-12-11 |
2008-09-16 |
Medarex, Inc. |
Enzyme-cleavable prodrug compounds
|
|
ATE220917T1
(de)
|
1999-01-26 |
2002-08-15 |
Lilly Co Eli |
Monodisperse formulierungen, die hexamere acylierte insulinanaloge enthalten
|
|
AU2879100A
(en)
|
1999-02-12 |
2000-08-29 |
Miles A. Libbey Iii |
Formulation and system for intra-oral delivery of pharmaceutical agents
|
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
|
WO2000061178A1
(en)
|
1999-04-13 |
2000-10-19 |
Inhale Therapeutics Systems, Inc. |
Pulmonary administration of dry powder formulations for treating infertility
|
|
WO2000064940A1
(en)
|
1999-04-27 |
2000-11-02 |
Eli Lilly And Company |
Insulin crystals for pulmonary administration
|
|
US6746853B1
(en)
|
1999-05-19 |
2004-06-08 |
Xencor, Inc. |
Proteins with insulin-like activity useful in the treatment of diabetes
|
|
JP2003518917A
(ja)
|
1999-05-19 |
2003-06-17 |
ゼンコー |
糖尿病の処置に有用なインシュリン様活性を有する新規タンパク質
|
|
US6309633B1
(en)
|
1999-06-19 |
2001-10-30 |
Nobex Corporation |
Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
|
|
AU5453300A
(en)
|
1999-06-29 |
2001-01-31 |
Eli Lilly And Company |
Insulin crystals for pulmonary administration
|
|
AU777570B2
(en)
|
1999-12-16 |
2004-10-21 |
Eli Lilly And Company |
Polypeptide compositions with improved stability
|
|
US6734162B2
(en)
|
2000-01-24 |
2004-05-11 |
Minimed Inc. |
Mixed buffer system for stabilizing polypeptide formulations
|
|
DK1265630T3
(da)
|
2000-03-24 |
2006-10-09 |
Genentech Inc |
Anvendelse af insulin til behandling af brusksygdomme
|
|
WO2001092334A1
(en)
|
2000-06-02 |
2001-12-06 |
Novo Nordisk A/S |
Glucose dependent release of insulin from glucose sensing insulin derivatives
|
|
CN1141974C
(zh)
|
2000-06-07 |
2004-03-17 |
张昊 |
结肠定位释放的口服生物制剂
|
|
US6459965B1
(en)
|
2000-11-22 |
2002-10-01 |
Ge-Harris Railway Electronics, Llc |
Method for advanced communication-based vehicle control
|
|
KR100508695B1
(ko)
|
2001-02-13 |
2005-08-17 |
한국과학기술연구원 |
인슐린의 경구투여용 제형과 그의 제조방법
|
|
US7060675B2
(en)
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
|
US6867183B2
(en)
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
|
WO2002067969A2
(en)
|
2001-02-21 |
2002-09-06 |
Medtronic Minimed, Inc. |
Stabilized insulin formulations
|
|
CN1160122C
(zh)
|
2001-04-20 |
2004-08-04 |
清华大学 |
一种制备口服胰岛素油相制剂的方法
|
|
CZ20033182A3
(cs)
|
2001-05-21 |
2004-09-15 |
Nektar Therapeutics |
Inzulínový prostředek a způsob podávání inzulínu
|
|
US6828297B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
US6858580B2
(en)
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
EP1423136A4
(en)
|
2001-08-10 |
2007-07-25 |
Epix Pharm Inc |
POLYPEPTIDE CONJUGATES HAVING INCREASED CIRCULATION HALF-VIES
|
|
US7030082B2
(en)
|
2001-09-07 |
2006-04-18 |
Nobex Corporation |
Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
|
|
US6770625B2
(en)
|
2001-09-07 |
2004-08-03 |
Nobex Corporation |
Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
|
|
US7312192B2
(en)
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
|
AR036449A1
(es)
|
2001-09-07 |
2004-09-08 |
Nobex Corp |
Metodos para sintetizar conjugados polipeptido insulinico-oligomero y conjugados polipeptido proinsulinico-oligomero y metodos para sintetizar dichos conjugados
|
|
US7317000B2
(en)
|
2001-12-02 |
2008-01-08 |
Novo Nordisk A/S |
Glucose-dependent insulins
|
|
AU2002349295A1
(en)
|
2001-12-02 |
2003-06-17 |
Novo Nordisk A/S |
Glucose dependant release of insulin from glucose sensing insulin derivatives
|
|
CA2468845C
(en)
|
2001-12-03 |
2011-08-23 |
Dor Biopharma Inc. |
Stabilized reverse micelle compositions and uses thereof
|
|
WO2003050276A1
(en)
|
2001-12-05 |
2003-06-19 |
Dow Global Technologies Inc. |
Method for immobilizing a biologic in a polyurethane-hydrogel composition, a composition prepared from the method, and biomedical applications
|
|
AU2002346491A1
(en)
|
2001-12-19 |
2003-07-09 |
Eli Lilly And Company |
Crystalline compositions for controlling blood glucose
|
|
JP2005519041A
(ja)
|
2001-12-20 |
2005-06-30 |
イーライ・リリー・アンド・カンパニー |
長期作用を備えたインスリン分子
|
|
UA46669C2
(uk)
|
2001-12-29 |
2005-12-15 |
Товариство З Обмеженою Відповідальністю "Мако" |
Спосіб приготування готової лікарської форми інсуліну пролонгованої дії
|
|
AU2003208316A1
(en)
|
2002-03-13 |
2003-09-22 |
Novo Nordisk A/S |
Minimising body weight gain in insulin treatment
|
|
ATE496064T1
(de)
|
2002-05-07 |
2011-02-15 |
Novo Nordisk As |
Lösliche formulierungen, die monomeres insulin und acyliertes insulin enthalten
|
|
AU2003218635A1
(en)
|
2002-05-07 |
2003-11-11 |
Novo Nordisk A/S |
Soluble formulations comprising insulin aspart and insulin detemir
|
|
US7601688B2
(en)
|
2002-06-13 |
2009-10-13 |
Biocon Limited |
Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
|
|
CN1165549C
(zh)
|
2002-06-15 |
2004-09-08 |
江苏万邦生化医药股份有限公司 |
胰岛素的纯化方法
|
|
WO2004026794A2
(en)
|
2002-09-17 |
2004-04-01 |
Merck & Co., Inc. |
Removal of aldehyde impurity by reactive polystyrene resin
|
|
US20040185068A1
(en)
|
2003-03-18 |
2004-09-23 |
Zhi-Jian Yu |
Self-emulsifying compositions, methods of use and preparation
|
|
JP2007524592A
(ja)
|
2003-06-03 |
2007-08-30 |
ノボ・ノルデイスク・エー／エス |
安定化された薬学的ペプチド組成物
|
|
ATE529126T1
(de)
|
2003-06-03 |
2011-11-15 |
Novo Nordisk As |
Stabilisierte pharmazeutische peptid zusammensetzungen
|
|
JP4864701B2
(ja)
|
2003-06-17 |
2012-02-01 |
セムバイオシス ジェネティクス インコーポレイテッド |
植物におけるインスリンの製造方法
|
|
US20050054818A1
(en)
|
2003-07-02 |
2005-03-10 |
Brader Mark Laurence |
Crystalline compositions for controlling blood glucose
|
|
WO2005005477A2
(en)
|
2003-07-11 |
2005-01-20 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
|
DK1648933T3
(da)
|
2003-07-25 |
2009-09-07 |
Conjuchem Biotechnologies Inc |
Langvarige insulinderivater og fremgangsm der
|
|
EP2107069B1
(en)
|
2003-08-05 |
2013-01-16 |
Novo Nordisk A/S |
Novel insulin derivatives
|
|
US20060198819A1
(en)
|
2003-08-08 |
2006-09-07 |
Novo Nordisk Healthcare A/G |
Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest
|
|
WO2005016312A1
(en)
|
2003-08-13 |
2005-02-24 |
Nobex Corporation |
Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
|
|
EP2932981B1
(en)
|
2003-09-19 |
2021-06-16 |
Novo Nordisk A/S |
Albumin-binding derivatives of GLP-1
|
|
US20050118206A1
(en)
|
2003-11-14 |
2005-06-02 |
Luk Andrew S. |
Surfactant-based gel as an injectable, sustained drug delivery vehicle
|
|
JP2007532096A
(ja)
*
|
2003-11-14 |
2007-11-15 |
ノボ ノルディスク アクティーゼルスカブ |
アシル化されたインスリンの製造方法
|
|
CN113304250A
(zh)
|
2003-11-20 |
2021-08-27 |
诺和诺德股份有限公司 |
对于生产和用于注射装置中是最佳的含有丙二醇的肽制剂
|
|
WO2005058961A2
(en)
|
2003-12-12 |
2005-06-30 |
Amgen Inc. |
Antibodies specific for human galanin, and uses thereof
|
|
DE10358387A1
(de)
|
2003-12-13 |
2005-07-07 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pulver enthaltend niedermolekulares Dextran und Verfahren zu deren Herstellung
|
|
WO2005092301A1
(en)
|
2004-03-26 |
2005-10-06 |
Universita' Degli Studi Di Parma |
Insulin highly respirable microparticles
|
|
WO2006097793A2
(en)
|
2004-04-15 |
2006-09-21 |
Chiasma, Ltd. |
Compositions capable of facilitating penetration across a biological barrier
|
|
EP1750756A2
(en)
|
2004-05-10 |
2007-02-14 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for enhanced mucosal delivery of parathyroid hormone
|
|
MXPA06015049A
(es)
|
2004-07-08 |
2007-02-08 |
Novo Nordisk As |
Marcadores prolongadores de polipeptidos que comprenden una porcion tetrazol.
|
|
WO2006005683A1
(en)
|
2004-07-09 |
2006-01-19 |
Novo Nordisk A/S |
Phamaceutical preparations comprising insulin
|
|
CN103223160B
(zh)
|
2004-07-19 |
2015-02-18 |
比奥孔有限公司 |
胰岛素-低聚物共轭物,制剂及其用途
|
|
WO2006020580A2
(en)
|
2004-08-09 |
2006-02-23 |
Alios Biopharma Inc. |
Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same
|
|
ES2540853T3
(es)
|
2004-08-23 |
2015-07-14 |
Mannkind Corporation |
Sales de dicetopiperazina para la administración de fármacos
|
|
EP2322146B1
(en)
|
2004-09-27 |
2012-12-12 |
Sigmoid Pharma Limited |
Microcapsule formulations comprising two pharmaceutically active ingredients
|
|
ES2540754T3
(es)
|
2004-12-03 |
2015-07-13 |
Rhode Island Hospital |
Diagnóstico y tratamiento de la Enfermedad de Alzheimer
|
|
WO2006079641A2
(en)
|
2005-01-27 |
2006-08-03 |
Novo Nordisk A/S |
Insulin derivatives conjugated with structurally well defined branched polymers
|
|
EP1846446B1
(en)
|
2005-02-02 |
2013-06-26 |
Novo Nordisk A/S |
Insulin derivatives
|
|
ES2435522T3
(es)
|
2005-02-02 |
2013-12-20 |
Novo Nordisk A/S |
Derivados de insulina
|
|
US20090123563A1
(en)
|
2005-02-07 |
2009-05-14 |
Novo Nordisk A/S |
Pharmaceutical Preparations Comprising Insulin, Zinc Ions and Zinc-Binding Ligand
|
|
WO2006086856A1
(en)
|
2005-02-15 |
2006-08-24 |
Messadek, Jallal |
Combination therapeutic compositions and method of use
|
|
JP2008533100A
(ja)
|
2005-03-18 |
2008-08-21 |
ノボ ノルディスク アクティーゼルスカブ |
Ｐｅｇ化された単鎖インスリン
|
|
TWI362392B
(en)
|
2005-03-18 |
2012-04-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
|
WO2006103657A2
(en)
|
2005-03-31 |
2006-10-05 |
Dexcel Pharma Technologies Ltd. |
A solid composition for intra-oral delivery of insulin
|
|
CN101193652B
(zh)
|
2005-04-08 |
2011-11-02 |
安米林药品公司 |
包含肠降血糖素肽和非质子极性溶剂的药物制剂
|
|
WO2006125763A1
(en)
|
2005-05-25 |
2006-11-30 |
Novo Nordisk A/S |
Stabilized polypeptide formulations
|
|
WO2007006320A1
(en)
|
2005-07-12 |
2007-01-18 |
Sherine Hassan Abbas Helmy |
Drinkable oral insulin liquid and capsules
|
|
WO2007041481A1
(en)
|
2005-09-29 |
2007-04-12 |
Biodel, Inc. |
Rapid acting and prolonged acting insulin preparations
|
|
JP4710533B2
(ja)
|
2005-10-07 |
2011-06-29 |
株式会社豊田自動織機 |
牽引車両のドローバー装置
|
|
AU2006304757A1
(en)
|
2005-10-20 |
2007-04-26 |
Nastech Pharmaceutical Company Inc. |
Intranasal administration of rapid acting insulin
|
|
EP2505593A1
(en)
|
2005-12-28 |
2012-10-03 |
Novo Nordisk A/S |
Compositions comprising an acylated insulin and zinc and method of making the said compositions
|
|
US8343914B2
(en)
|
2006-01-06 |
2013-01-01 |
Case Western Reserve University |
Fibrillation resistant proteins
|
|
EP1991575A1
(en)
|
2006-02-21 |
2008-11-19 |
Novo Nordisk A/S |
Single-chain insulin analogues and pharmaceutical formulations thereof
|
|
ATE482977T1
(de)
*
|
2006-02-27 |
2010-10-15 |
Novo Nordisk As |
Insulinderivate
|
|
JP2009530243A
(ja)
|
2006-03-13 |
2009-08-27 |
ノボ・ノルデイスク・エー／エス |
アシル化単鎖インスリン
|
|
US20090069215A1
(en)
|
2006-03-13 |
2009-03-12 |
Novo Nordisk A/S |
Acylated Single Chain Insulin
|
|
WO2007128815A1
(en)
|
2006-05-09 |
2007-11-15 |
Novo Nordisk A/S |
Insulin derivative
|
|
JP5269767B2
(ja)
|
2006-05-09 |
2013-08-21 |
ノボ・ノルデイスク・エー／エス |
インスリン誘導体
|
|
CN101573133B
(zh)
|
2006-07-31 |
2014-08-27 |
诺沃-诺迪斯克有限公司 |
Peg化延长的胰岛素
|
|
KR101729986B1
(ko)
|
2006-09-22 |
2017-04-25 |
노보 노르디스크 에이/에스 |
프로테아제 내성 인슐린 유사체
|
|
EP2074140B8
(en)
|
2006-10-04 |
2015-10-28 |
Case Western Reserve University |
Fibrillation-resistant insulin and insulin analogues
|
|
US9387176B2
(en)
|
2007-04-30 |
2016-07-12 |
Novo Nordisk A/S |
Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
|
|
WO2008132229A2
(en)
|
2007-04-30 |
2008-11-06 |
Novo Nordisk A/S |
Highly concentrated insulin solutions and compositions
|
|
WO2008145728A1
(en)
|
2007-06-01 |
2008-12-04 |
Novo Nordisk A/S |
Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier
|
|
AU2008257505B2
(en)
|
2007-06-01 |
2013-05-16 |
Novo Nordisk A/S |
Stable non-aqueous pharmaceutical compositions
|
|
EP2167032B1
(en)
|
2007-06-13 |
2019-08-07 |
Novo Nordisk A/S |
Pharmaceutical formulation comprising an insulin derivative
|
|
EP2170945A1
(en)
|
2007-07-16 |
2010-04-07 |
Novo Nordisk A/S |
Protease stabilized, pegylated insulin analogues
|
|
EP2178909B1
(en)
|
2007-08-13 |
2015-10-21 |
Novo Nordisk A/S |
Rapid acting insulin analogues
|
|
WO2009022006A1
(en)
*
|
2007-08-15 |
2009-02-19 |
Novo Nordisk A/S |
Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids
|
|
EP2178912B1
(en)
*
|
2007-08-15 |
2015-07-08 |
Novo Nordisk A/S |
Insulin analogues with an acyl and aklylene glycol moiety
|
|
US20090087484A1
(en)
|
2007-09-28 |
2009-04-02 |
Alza Corporation |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
|
|
MX2010005245A
(es)
|
2007-11-16 |
2010-06-01 |
Novo Nordisk As |
Composiciones farmaceuticas que comprenden peptidos glp-1 o exendin-4 y un peptido de insulina basal.
|
|
ES2618073T3
(es)
|
2008-03-14 |
2017-06-20 |
Novo Nordisk A/S |
Análogos de insulina estabilizados frente a proteasas
|
|
EP2910569B1
(en)
|
2008-03-18 |
2016-10-05 |
Novo Nordisk A/S |
Protease stabilized, acylated insulin analogues
|
|
US8993516B2
(en)
|
2008-04-14 |
2015-03-31 |
Case Western Reserve University |
Meal-time insulin analogues of enhanced stability
|
|
TWI451876B
(zh)
|
2008-06-13 |
2014-09-11 |
Lilly Co Eli |
聚乙二醇化之離脯胰島素化合物
|
|
BRPI0919946A2
(pt)
|
2008-10-30 |
2016-02-16 |
Novo Nordisk As |
tratamento de diabetes melito usando injeções de insulina com frequência de injeção menor que diariamente
|
|
WO2010060667A1
(en)
|
2008-11-28 |
2010-06-03 |
Novo Nordisk A/S |
Pharmaceutical compositions suitable for oral administration of derivatized insulin peptides
|
|
CN102245633A
(zh)
|
2008-12-09 |
2011-11-16 |
诺沃—诺迪斯克有限公司 |
新的胰岛素类似物
|
|
WO2011033019A1
(en)
|
2009-09-16 |
2011-03-24 |
Novo Nordisk A/S |
Stable non-aqueous liquid pharmaceutical compositions comprising an insulin
|
|
WO2011051486A2
(en)
|
2009-11-02 |
2011-05-05 |
Novo Nordisk A/S |
Pharmaceutical solution of non covalently bound albumin and acylated insulin
|
|
CN102770469B
(zh)
|
2009-11-23 |
2015-04-15 |
巴斯夫欧洲公司 |
制备具有改善的色彩稳定性的吸水性聚合物颗粒的方法
|
|
CN102753150A
(zh)
|
2010-01-12 |
2012-10-24 |
诺沃—诺迪斯克有限公司 |
用于口服给予胰岛素肽的药物组合物
|
|
CN102985440B
(zh)
|
2010-06-23 |
2016-10-26 |
诺沃-诺迪斯克有限公司 |
包含额外的二硫键的胰岛素衍生物
|
|
WO2011161124A1
(en)
|
2010-06-23 |
2011-12-29 |
Novo Nordisk A/S |
Insulin analogues containing additional disulfide bonds
|
|
WO2012049307A2
(en)
|
2010-10-15 |
2012-04-19 |
Novo Nordisk A/S |
Novel n-terminally modified insulin derivatives
|
|
WO2012080320A1
(en)
|
2010-12-14 |
2012-06-21 |
Novo Nordisk A/S |
Fast-acting insulin in combination with long-acting insulin
|
|
CN103596584B
(zh)
|
2011-06-15 |
2016-12-14 |
诺沃—诺迪斯克有限公司 |
多取代的胰岛素
|
|
AU2013247047A1
(en)
|
2012-04-11 |
2014-10-23 |
Novo Nordisk A/S |
Insulin formulations
|
|
US20150111820A1
(en)
|
2012-07-09 |
2015-04-23 |
Novo Nordisk A/S |
Novel use of insulin derivatives
|
|
WO2014177623A1
(en)
|
2013-04-30 |
2014-11-06 |
Novo Nordisk A/S |
Novel administration regime
|
|
PL3055325T3
(pl)
|
2013-10-07 |
2018-06-29 |
Novo Nordisk A/S |
Nowa pochodna analogu insuliny
|
|
FR3013049B1
(fr)
|
2013-11-14 |
2015-11-13 |
You-Ping Chan |
Analogue de l'insuline glargine
|
|
EP3113791B1
(en)
|
2014-03-07 |
2018-12-26 |
Jørgensen, Klavs Holger |
Novel fast acting insulin preparations
|
|
TWI685348B
(zh)
|
2014-05-08 |
2020-02-21 |
美國禮來大藥廠 |
速效胰島素組合物
|
|
AR102869A1
(es)
|
2014-12-16 |
2017-03-29 |
Lilly Co Eli |
Composiciones de insulina de rápida acción
|
|
HRP20221324T1
(hr)
|
2016-12-16 |
2022-12-23 |
Novo Nordisk A/S |
Farmaceutski pripravci koji sadrže inzulin
|